pantoprazole has been researched along with Remission, Spontaneous in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sennaroglu, E | 1 |
| Karakan, S | 1 |
| Kayatas, M | 1 |
| Akdur, S | 1 |
| Genc, H | 1 |
| Karakan, T | 1 |
| Ucler, R | 1 |
| Ozisler, C | 1 |
| Urun, Y | 1 |
1 other study available for pantoprazole and Remission, Spontaneous
| Article | Year |
|---|---|
Reversible edema in a male patient taking parenteral pantoprazole infusion for pyloric stenosis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Edema; Follow-Up | 2006 |